Dear Seed Investor,
UNDERSTANDING INMED: Drug Development IP to Pipeline.
Cannabis Biotechs lead the Bloomberg Weed Index* this year, and one of the reasons InMed is poised to explode. Already up over ~400% year over year...they continue innovating in the space.
To understand the reasons why InMed is so well positioned in this Billion dollar space, Visual Capitalist profiled the Company with
Click the image below to view the full Company Spotlight (InMed Infographic).
The Seed Investor
Bloomberg Weed Index Click Here: *https://www.bloomberg.com/graphics/2017-weed-index/